COMBINATORIAL IMMUNOTHERAPEUTIC AND TARGETED KINASE INHIBITION APPROACH IN KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Niswander, Lisa [1 ]
Mcclellan, Samantha [1 ]
Shraim, Rawan [1 ]
Falkenstein, Catherine [1 ]
Yarnell, Michael [2 ]
Meadows, Christina [2 ]
Fry, Terry [2 ]
Tasian, Sarah [1 ]
机构：
[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA
[2] Childrens Hosp Colorado, Div Hematol Oncol Bmt, Aurora, CO USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O208
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] Allelic imbalance in KMT2A-rearranged infant acute lymphoblastic leukemia
    Yoo, Byunggil
    Farooqi, Midhat S.
    Kostadinov, Rumen
    Cheung, Warren
    Farrow, Emily
    Kelley, Shannon
    Miller, Neil
    Ge, Bing
    Gibson, Margaret
    Brown, Patrick
    Guest, Erin M.
    Pastinen, Tomi
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Cheung, Laurence C.
    de Kraa, Rebecca
    Oommen, Joyce
    Chua, Grace-Alyssa
    Singh, Sajla
    Hughes, Anastasia M.
    Ferrari, Emanuela
    Ford, Jette
    Chiu, Sung K.
    Stam, Ronald W.
    Kees, Ursula R.
    Malinge, Sebastien
    Kotecha, Rishi S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia
    Chiu, Sung K.
    Ferrari, Emanuela
    Oommen, Joyce
    Malinge, Sebastien
    Cheung, Laurence C.
    Kotecha, Rishi S.
    CANCERS, 2025, 17 (03)
  • [4] Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia
    Verbeek, Tamara C. A. I.
    Vrenken, Kirsten S.
    Arentsen-Peters, Susan T. C. J. M.
    Castro, Patricia Garrido
    van de Ven, Marieke
    van Tellingen, Olaf
    Pieters, Rob
    Stam, Ronald W.
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [5] Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia
    Burmeister, Thomas
    Stroeh, Aeint-Steffen
    Kehden, Britta
    Trautmann, Heiko
    Meyer, Claus
    Marschalek, Rolf
    Larghero, Patrizia
    Schwartz, Stefan
    Steffen, Bjoern
    Spriewald, Bernd
    Heinicke, Thomas
    Jaekel, Nadja
    Westermann, Joerg
    Nachtkamp, Kathrin
    Viardot, Andreas
    Topp, Max S.
    Neumann, Martin
    Baldus, Claudia D.
    Goekbuget, Nicola
    Brueggemann, Monika
    LEUKEMIA, 2024, 38 (07) : 1600 - 1603
  • [6] Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia
    Adriaanse, Fabienne R. S.
    Schneider, Pauline
    Arentsen-Peters, Susan T. C. J. M.
    da Fonseca, Ana M. Neves
    Stutterheim, Janine
    Pieters, Rob
    Zwaan, C. Michel
    Stam, Ronald W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [7] DYRK1A Is Regulated By Oncogenic KMT2A and Required for Survival of KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Hurtz, Christian
    Wertheim, Gerald
    Bhansali, Rahul S.
    Lehman, Anne
    Jeschke, Grace
    Crispino, John D.
    Besson, Thierry
    Tasian, Sarah K.
    Carroll, Martin
    BLOOD, 2019, 134
  • [8] DYRK1A Is Required to Alleviate Replication Stress in KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Hurtz, Christian
    Carroll, Martin P.
    Tasian, Sarah K.
    Wertheim, Gerald
    Bhansali, Rahul S.
    Lee, Sung June
    Kumar, Anil
    Lehman, Anne
    Loftus, Joseph Patrick
    Jeschke, Grace
    Crispino, John D.
    Besson, Thierry
    Shi, Junwei
    Swaminathan, Srividya
    BLOOD, 2020, 136
  • [9] Establishment and Characterization of a Model of Acquired Resistance to DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic Leukemia Cells
    Schneider, Pauline
    Arentsen-Peters, Susan T. C. J. M.
    Crump, Nicholas T.
    Smith, Alastair
    Hagelaar, Rico
    Adriaanse, Fabienne R. S.
    Bos, Romy S.
    Vrenken, Kirsten S.
    Rockx-Brouwer, Dedeke
    Tang, Ziqin
    Vermeij, Wilbert P.
    De Jong, Anja
    Koopmans, Bianca
    Dolman, M. Emmy M.
    Milne, Thomas A.
    Pieters, Rob
    Stam, Ronald W.
    BLOOD, 2022, 140 : 8760 - 8761
  • [10] Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia
    Schneider, Pauline
    Crump, Nicholas T.
    Arentsen-Peters, Susan T. C. J. M.
    Smith, Alastair L.
    Hagelaar, Rico
    Adriaanse, Fabienne R. S.
    Bos, Romy S.
    de Jong, Anja
    Nierkens, Stefan
    Koopmans, Bianca
    Milne, Thomas A.
    Pieters, Rob
    Stam, Ronald W.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
12345